Hope for heart disease glucose treatment

Scientists are on their way to a treatment to help patients with cardiovascular disease linked to high glucose levels, it has been announced.

The Leicester University, UK, researchers have been studying the mechanisms which lead blood glucose to cause vascular contraction.

The study has also shown how high glucose levels can increase blood pressure and trigger cardiovascular disease.

The research, reported in the British Journal of Pharmacology, used electrophysiology and myography techniques in laboratory studies.

It has shown that the protein kinase C – PKC – plays a key role, suggesting a target for drug treatments.

Researcher Dr Richard Rainbow, a lecturer in cardiovascular cell physiology, “We have shown that the amount of sugar, or glucose, in the blood changes the behaviour of blood vessels making them contract more than normal. This could result in higher blood pressure, or could reduce the amount of blood that flows through vital organs.

“This was an experimental lab study which means that we can draw conclusions about cause and effect in a controlled environment. Here, we have identified a known signalling protein family, protein kinase C, is a key part of this enhanced contractile response, and have also shown in our experiments that we can restore the normal level of contractile response, and reverse the effects on the heart, with inhibitors of these proteins.

“This is the first study to show direct evidence of blood vessel contraction to glucose, and the potential mechanism behind this contractile response.”

He added: “Targeting the specific types of protein kinase C that we’ve shown to be involved in this can provide a novel therapeutic route for improving outcome in ischaemic diseases, such as heart attack or stroke.”

Professor Jeremy Pearson, from the British Heart Foundation, added: “This team have shown that, in multiple species, it is possible to use PKC as a target to block blood vessel constriction caused by high levels of glucose in the blood.

“This opens up the possibility for improved treatment for patients where recovery from heart attack is complicated by raised glucose levels.”

Distinct and complementary roles for a and ß isoenzymes of protein kinase C in mediating vasoconstrictor responses to acutely elevated glucose. British Journal of Pharmacology January 2016 [abstract]

, , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index